Contrasting NewGenIvf Group (NASDAQ:NIVF) and Marpai (NASDAQ:MRAI)

NewGenIvf Group (NASDAQ:NIVF) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Valuation and Earnings

This table compares NewGenIvf Group and Marpai”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$5.14 million	0.47	$130,000.00	N/A	N/A
Marpai	$34.87 million	0.16	-$28.75 million	($3.19)	-0.16

NewGenIvf Group has higher earnings, but lower revenue than Marpai.

Profitability

This table compares NewGenIvf Group and Marpai’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
Marpai	-92.76%	N/A	-99.32%

Analyst Ratings

This is a breakdown of current ratings and price targets for NewGenIvf Group and Marpai, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	0	0	0	0	N/A
Marpai	0	0	1	0	3.00

Marpai has a consensus target price of $6.00, suggesting a potential upside of 1,100.00%. Given Marpai’s higher possible upside, analysts plainly believe Marpai is more favorable than NewGenIvf Group.

Insider and Institutional Ownership

66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by insiders. Comparatively, 61.3% of Marpai shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk & Volatility

NewGenIvf Group has a beta of 0.29, meaning that its stock price is 71% less volatile than the S&P 500. Comparatively, Marpai has a beta of 4.85, meaning that its stock price is 385% more volatile than the S&P 500.

About NewGenIvf Group

A SPAC I Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. A SPAC I Acquisition Corp. is based in Singapore.

About Marpai

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.